Delaware 2023 2023-2024 Regular Session

Delaware Senate Bill SCR33 Draft / Bill

                    SPONSOR:      Sen. Poore & Rep. Minor-Brown       Sens. Hansen, Pinkney; Reps. Briggs King, Griffith, K. Johnson           DELAWARE STATE SENATE   152nd GENERAL ASSEMBLY       SENATE CONCURRENT RESOLUTION NO. 33       DESIGNATING MAY 17, 2023, AS TARDIVE DYSKINESIA AWARENESS WEEK IN DELAWARE.      

     

     SPONSOR:      Sen. Poore & Rep. Minor-Brown       Sens. Hansen, Pinkney; Reps. Briggs King, Griffith, K. Johnson     

SPONSOR: Sen. Poore & Rep. Minor-Brown
Sens. Hansen, Pinkney; Reps. Briggs King, Griffith, K. Johnson

 SPONSOR:  

 Sen. Poore & Rep. Minor-Brown 

 Sens. Hansen, Pinkney; Reps. Briggs King, Griffith, K. Johnson 

   

 DELAWARE STATE SENATE 

 152nd GENERAL ASSEMBLY 

   

 SENATE CONCURRENT RESOLUTION NO. 33 

   

 DESIGNATING MAY 17, 2023, AS TARDIVE DYSKINESIA AWARENESS WEEK IN DELAWARE. 

   

  WHEREAS, May is National Mental Health Awareness Month; and    WHEREAS, Tardive Dyskinesia is a movement disorder that disproportionately affects people being treated for chronic mental health conditions, including schizophrenia, bipolar disorder, and severe depression; and    WHEREAS, ongoing treatment with prescription antipsychotic medications has many benefits for those with these and other mental illnesses; and    WHEREAS, antipsychotic medications may lead to Tardive Dyskinesia in one out of every four patients receiving long-term treatment; and    WHEREAS, Tardive Dyskinesia is characterized by random, involuntary, and uncontrollable movements of muscles in the face, trunk, and extremities; and    WHEREAS, Tardive Dyskinesia can develop long after a person begins treatment, or even after the discontinuation of treatment with antipsychotic medications; and    WHEREAS, once Tardive Dyskinesia develops, it is often permanent; and    WHEREAS, over 600,000 Americans have been diagnosed with Tardive Dyskinesia, with many more suffering, although unaware of the cause or having been misdiagnosed; and    WHEREAS, scientific breakthroughs and years of research have allowed the Food and Drug Administration to recently approve two new treatments for the symptoms related to Tardive Dyskinesia; and    WHEREAS, it is important to raise further awareness of this disorder throughout the community.   NOW, THEREFORE:   BE IT RESOLVED by the Senate of the 152nd General Assembly of the State of Delaware, the House of Representatives concurring therein, that the week of May 1-7, 2023, is designated as Tardive Dyskinesia Awareness Week in the State of Delaware.    BE IT FURTHER RESOLVED that this General Assembly encourages all Delawareans to become better informed about Tardive Dyskinesia.       

 WHEREAS, May is National Mental Health Awareness Month; and  

 WHEREAS, Tardive Dyskinesia is a movement disorder that disproportionately affects people being treated for chronic mental health conditions, including schizophrenia, bipolar disorder, and severe depression; and  

 WHEREAS, ongoing treatment with prescription antipsychotic medications has many benefits for those with these and other mental illnesses; and  

 WHEREAS, antipsychotic medications may lead to Tardive Dyskinesia in one out of every four patients receiving long-term treatment; and  

 WHEREAS, Tardive Dyskinesia is characterized by random, involuntary, and uncontrollable movements of muscles in the face, trunk, and extremities; and  

 WHEREAS, Tardive Dyskinesia can develop long after a person begins treatment, or even after the discontinuation of treatment with antipsychotic medications; and  

 WHEREAS, once Tardive Dyskinesia develops, it is often permanent; and  

 WHEREAS, over 600,000 Americans have been diagnosed with Tardive Dyskinesia, with many more suffering, although unaware of the cause or having been misdiagnosed; and  

 WHEREAS, scientific breakthroughs and years of research have allowed the Food and Drug Administration to recently approve two new treatments for the symptoms related to Tardive Dyskinesia; and  

 WHEREAS, it is important to raise further awareness of this disorder throughout the community. 

 NOW, THEREFORE: 

 BE IT RESOLVED by the Senate of the 152nd General Assembly of the State of Delaware, the House of Representatives concurring therein, that the week of May 1-7, 2023, is designated as Tardive Dyskinesia Awareness Week in the State of Delaware.  

 BE IT FURTHER RESOLVED that this General Assembly encourages all Delawareans to become better informed about Tardive Dyskinesia.  

   

  SYNOPSIS   This resolution designates the week of May 1-7, 2023, as "Tardive Dyskinesia Awareness Week" in Delaware.         Author: Senator Poore  

 SYNOPSIS 

 This resolution designates the week of May 1-7, 2023, as "Tardive Dyskinesia Awareness Week" in Delaware. 

  

  

 Author: Senator Poore